Type : Contract
SMALL MOLECULES AND/OR BIOLOGICS MEDICINAL CHEMISTRY CONSULTANT SUPPORT SERVICES Solicitation ID/Procurement Identifier: 75N95023Q00081 Ultimate Completion Date: Sat Mar 28 17:00:00 GMT 2026
SMALL MOLECULES AND/OR BIOLOGICS MEDICINAL CHEMISTRY CONSULTANT SUPPORT SERVICES Solicitation ID/Procurement Identifier: 75N95023Q00081 Ultimate Completion Date: Sat Mar 28 17:00:00 GMT 2026
(vi) Purpose and Objectives: The purpose of this requirement is to procure up to three (3) consultants to provide technical recommendations to the NIH Blueprint Neurotherapeutics Network drug discovery and development program in the area of Medicinal Chemistry.
The purpose of this requirement is to procure consultant services to provide technical recommendations to the NIH Blueprint Neurotherapeutics Network drug discovery and development programs in the area of Medicinal Chemistry.Please see Attachment 1 - Purchase Description for additional information.
Statement of Need and Purpose: The NIH is seeking executive (senior scientific)-level, industry-experienced drug discovery and development consultants with expertise in Medicinal Chemistry to provide technical guidance in the area of Medicinal Chemistry to the following programs:• Medicinal Chemistry consulting to procure consultant services to provide technical recommendations to the NIH Blueprint Neurotherapeutics Network drug discovery and development
Medicinal Chemistry Consultant Support Services
The NINDS is seeking to procure consulting services from executive (senior scientific)-level, industry-experienced drug discovery and development consultants with expertise in small molecule medicinal chemistry, to provide technical guidance to one or more of the following programs: National Institutes of Health Blueprint Neurotherapeutics Network NIH Helping to End Addiction Long-termSM Initiative Other NIH neuroscience-focused drug discovery
The role of the Assay Development consultant may include but is not limited to the following responsibilities and tasks: • Consultants may be required to evaluate bioactivity assays and recommend strategies and experiments to optimize and/or validate the assays for use in a medicinal chemistry campaign. •Assay development consultants may be asked to assist in the establishment ofmilestones related to assay optimization or validation.